Titan Biotech Limited (BOM:524717)
India · Delayed Price · Currency is INR 366.40
+16.80 (4.81%)
At close: Nov 9, 2026
Titan Biotech Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 2,410 | 2,062 | 1,565 | 1,641 | 1,440 | 1,235 |
Revenue Growth | 38.25% | 31.79% | -4.64% | 13.94% | 16.55% | -13.14% |
Gross Profit Gross Profit Growth | 1,246 | 1,077 | 822.57 | 871.36 | 729.57 | 637.21 |
Operating Income Operating Income Growth | 426.33 | 335.3 | 211.1 | 308.08 | 268.05 | 288.13 |
Net Income Net Income Growth | 386.62 | 298.85 | 215.32 | 248.53 | 248.44 | 216.84 |
Earnings Per Share EPS Growth | 8.31 | 5.78 | 4.17 | 4.81 | 4.81 | 4.20 |
EPS Growth | 86.16% | 38.77% | -13.37% | 0.02% | 14.57% | -28.52% |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 1,259 | 1,025 | 1,076 | 997.99 | 959.16 |
Overseas Overseas Growth | 803.32 | 539.03 | 564.94 | 442.01 | 276.33 |
Total Total Growth | 2,062 | 1,565 | 1,641 | 1,440 | 1,235 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 47.29 | 18.73 | 55.58 | 32.86 | 48.64 | 68.14 |
Total Debt Total Debt Growth | 59.49 | 61.03 | 32.27 | 87.48 | 85.12 | 89.3 |
Net Cash (Debt) Net Cash Growth | -12.2 | -42.3 | 23.31 | -54.63 | -36.48 | -21.16 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.26 | -0.82 | 0.45 | -1.06 | -0.71 | -0.41 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 322.48 | 304.21 | 201.23 | 211.46 | 211.78 | 220.41 |
Capital Expenditures CapEx Growth | -113.38 | -74.28 | -85.21 | -194.85 | -127.34 | -63.11 |
Free Cash Flow Free Cash Flow Growth | 209.1 | 229.93 | 116.03 | 16.61 | 84.45 | 157.29 |
Free Cash Flow Growth | 45.80% | 98.16% | 598.38% | -80.33% | -46.31% | -2.13% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 51.72% | 52.21% | 52.58% | 53.11% | 50.66% | 51.58% |
Operating Margin | 17.69% | 16.26% | 13.49% | 18.78% | 18.62% | 23.32% |
Pretax Margin | 21.64% | 19.70% | 17.66% | 19.94% | 22.18% | 23.45% |
Profit Margin | 16.05% | 14.49% | 13.76% | 15.15% | 17.25% | 17.55% |
FCF Margin | 8.68% | 11.15% | 7.42% | 1.01% | 5.86% | 12.73% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.400 | 0.400 | 0.320 | 0.320 | 0.288 | 0.240 |
Dividend Per Share Growth | 25.00% | 25.00% | 0% | 11.11% | 20.00% | 0% |
Dividend Yield | 0.11% | 0.11% | 0.47% | 0.38% | 0.91% | 0.57% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 44.08 | 63.28 | 16.18 | 17.56 | 6.55 | 9.99 |
P/FCF Ratio | 90.50 | 82.25 | 30.02 | 262.72 | 19.26 | 13.77 |
PS Ratio | 7.85 | 9.17 | 2.23 | 2.66 | 1.13 | 1.75 |